Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q2 2022 · 10-Q
Revenue$9.67M$9.67M+54.1% vs Q2 2021 Net Income$769.43K$769.43KN/M vs Q2 2021 EPS Diluted$0.09$0.09N/M vs Q2 2021 Gross Profit$8,712,692+51.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,154,317N/M Free Cash Flowderived-$1,190,512N/M Margins · derivedGross margin90.1%−1.4 pt vs Q2 2021
Operating margin-35.0%−18.7 pt vs Q2 2021
Net margin8.0%+27.2 pt vs Q2 2021
ended Jun 30, 2022 · filed Aug 15, 2022 · 46 d after period end